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Addition of hydrocortisone to the rat mammary gland myoepithelial cell line, G4.2.3, induces the synthesis and secretion of a,-macroglobulin. 
Interleukin-lp, interleukin-6 and transforming growth factor-b synergise with hydrocortisone, increasing the synthesis of +macroglobulin 2- to 
Cfold, although they have no effect in the absence of hydrocortisone. Interleukin-6 is the most potent inducer having an optimum concentration 
of 1 ng/ml. Interleukind, unlike interleukin-l/3 or tranforming growth factor-fi, decreases the lag phase from 10 h to 4 h before o+macroglobulin 
synthesis is induced by hydrocortisone. These results suggest hat the mechanism of activation of transcription of the a,-macroglobulin gene in 
mammary myoepithelial cells might differ from that operating in hepatic cells. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
In the rat, a,-macroglobulin is an acute-phase pro- 
tein. Plasma levels of a,-macroglobulin, which is an 
inhibitor of all classes of proteases, rise about lOO-fold 
following an appropriate intlammatory stimulus [ 11. a2- 
Macroglobulin is primarily synthesised in the liver, al- 
though extra-hepatic sources, e.g. macrophages and 
some fibroblast and neuronal cell lines, have been de- 
scribed [24]. Recently, we have described the induction 
of the synthesis of R-macroglobulin and an unidentified 
protein (~146) in an immortalised rat mammary myoep- 
ithelial cell line by hydrocortisone, a lactogenic 
hormone [5]. Increased production of a,-macroglobulin 
during pregnancy may protect the mammary gland 
basement membrane and other extracellular matrix 
structures from excessive proteolysis. 
The synthesis of acute-phase proteins is regulated by 
glucocorticoids and inflammatory cytokines, e.g. inter- 
leukin-1 (IL-l), IL-6 and tumour necrosis factor-a 
(TNFa) [6,7& a,-Macroglobulin synthesis is primarily 
induced by IL-6 and is considerably further enhanced 
by glucocorticoids in vivo and in vitro [8,9]. The 
5’ flanking region of the rat a2-macroglobulin gene con- 
tains both IL-6 and glucocorticoid response elements 
[lO,l 11. The combination of factors required for maxi- 
mum stimulation of gene expression varies depending 
on the acute-phase protein and the cell line. We now 
report that the synthesis of a,-macroglobulin by the rat 
mammary myoepithelial cell line, G4.2.3, is regulated 
by synergy between glucocorticoids and cytokines. 
*Corresponding author. Fax: (44) (81) 767 8326. 
2.1. Materials 
IL-l/I and TNFa were purchased from Bachem (Saffron Walden, 
UK). IL-6 and TGF/I were obtained through British Biotechnology 
(Oxford, UK). [?S]Methionine was obtained from DuPont (Ste- 
venage, UK). 
2.2. Cell culture 
The derivation and characterisation of the rat mammary myo- 
epithelial cell line, G4.2.3, have been described previously [5,12]. This 
cell line has been infected with the SV4Oderived tsA58-Ul9 recombi- 
nant construct in the pZipneoSV(X) 1 vector [13] and shows decreased 
levels of nuclear T antigen, a decreased growth rate and an increase 
in the expression of differentiated characteristics at the non-permissive 
temperature (39YC) compared to the permissive temperature (33’C). 
Cells were routinely grown at 36°C and were switched to 39.5’C for 
72 h before the start of experiments. 
2.3. Metabolic labelling 
Cells were metabolically labelled by growth in methionine-free me- 
dium containing 20 @/ml i%]methionine. The culture medium was 
centrifuged, proteinase inhibitors (1 ,@nl leupeptin, 1 &ml pep- 
statin, 1 mM phenyhnethylsulphonyl fluoride and 5 mM EDTA) 
added, dialysed against water and freeze-dried. %-Labelled, secreted 
proteins were analysed by SDS-PAGE followed by fluorography. Au- 
toradiograms were scanned into a Macintosh LC computer and pro- 
tein bands quantified using the programme ScanAnalysis (Biosoft, 
Cambridge, UK). 
3. RESULTS 
Addition of hydrocortisone to G4.2.3 cells results in 
the induction of the synthesis and secretion of a2-mac- 
roglobulin and ~146 (Fig. 1). The production of these 
two proteins could be further increased by the addition 
of interleukin-6 (IL-6). IL-6 alone had no effect on the 
production of a,-macroglobulin or ~146 (Fig. 1). In 
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Fig. 1. SDS-PAGE of proteins secreted by G4.2.3 cells. Cells were 
cultured in the absence of any additions (a) or in the presence of 
1 PM bydrocortisone (b), 1 ng/ml IL-6 (c) or 1 PM hydrocortisone and 
1 @ml IL-6 (d). The medium was supplemented with [‘%]methionine 
(20 @X/ml). After 24 h incubation, the culture medium was dialysed 
against water, freeze-dried and analysed by SDS-PAGE followed by 
fluorography. Fn, fibronectin; a,M, o+macroglobulin. 
addition to IL-6, other cytokines and growth factors 
augmented the effects of hydrocortisone (Table I). IL- 
1B and TGF/? both stimulated the production of clz- 
macroglobulin and ~146 in the presence, but not in the 
absence, of hydrocortisone. There was no additional 
synergy between these stimulatory factors. TNFa was 
unable to stimulate the production of the two proteins, 
as were the two growth factors EGF (epidermal growth 
factor) and bFGF (basic fibroblast growth factor) (not 
shown). 
Dose-response curves for IL-lp, IL-6 and TGFB 
demonstrated that IL-6 was the most potent factor pro- 
ducing a maximum response at a concentration of 
Table I 
Effects of cytokines on the synthesis of R-macroglobulin and ~146 
induced by hydrocortisone 
Additions Relative synthesis 
~-Macro~ob~in p146 
- 1.0+0.1 1.0 2 0.2 
IL-l/? (1 @ml) 2.3 rt 0.3 3.1 f 0.3 
IL-6 (1 @ml) 3.5 F 0.2 5.7 f 0.5 
TNFd (1 ng/ml) 1.1 rt: 0.2 1.0 + 0.1 
TGF@ (5 ng/ml) 2.2 rt 0.3 2.7 f 0.3 
IL-l@ + IL-6 3.7 + 0.2 5.7 + 0.5 
IL-l/9 + TGFB 2.2 f: 0.1 3.2 -I 0.3 
IL-6 + TGFB 3.4 It 0.3 5.5 + 0.4 
IL-l/I + IL-6 + TGFB 3.8 + 0.2 5.6 + 0.5 
Cells were cultured in the presence of cytokines, 1 PM hydrocortisone 
and [3’S]metbionine (20 @/mI) for 24 h. Culture medium was analy- 
sed for the secretion of ~-m~oglob~in and ~146. Results are ex- 
pressed as fS.D. of 3 experiments. 
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Fig. 2. Effect of cytokine concentration on the production of a,- 
macroglobulin. G4.2.3 cells were cultured in the presence of 1 FM 
hydrocortisone and various concentrations of (A) IL-6, (B) IL-@ or 
(Cc) TGF#? and the culture medium analysed for the secretion of CQ- 
macroglob~in. The results are expressed as the concentration of czz- 
ma~o~ob~in relative to the ~on~nt~tion produced in the presence 
of hydrocortisone alone. 
1 ng/ml (Fig. 2). IL-l/3 required a concentration of 5 ng/ 
ml and TGFj3 a concentration in excess of 10 ng/ml for 
maximum stimulation of +macroglobulin production, 
Similar results were obtained for ~146 (data not shown). 
Addition of hydrocortisone to G4.2.3 cells results in 
the induction of c+macroglobulin production after a 
lag phase of 10-12 h (Fig. 3). Neither IL-@ nor TGFB 
altered the length of the lag phase. However, IL-6 re- 
duced the lag phase to 4-6 h. The time-course of the 
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Fig. 3. Time-course of the induction of cc,-macroglobulin synthesis by 
hydrocortisone and cytokines. G4.2.3 cells were cultured in the pres- 
ence of 1 PM hydrocortisone (0) or 1 PM hydrocortisone and 5 rig/ml 
IL-la (o), 5 q/ml TGFB (0) or 1 ng/ml IL-6 (A). At appropriate times, 
the culture medium was analysed for the presence of qmacroglob- 
ulin. The concentration of a,-macroglobulin is expressed in arbitrary 
units. 
induction of ~146 production was similar to that of 
a,-macroglobulin (data not shown). 
4. DISC JSSION 
The main function of a,-macroglobulin is to act as an 
inhibitor of proteases and to clear proteases from the 
circulation [l 11. The large size (720 kDa) of circulating 
cx,-macroglobulin may preclude its diffusion through 
extracellular matrices and may necessitate local produc- 
tion. During pregnancy, there is an enormous increase 
in the deposition of basement membrane by myoepithe- 
lial cells within the mammary gland [14]. Increased lev- 
els of hydrocortisone during pregnancy might induce 
the localised synthesis and secretion of a,-macroglob- 
ulin by myoepithelial cells reducing proteolysis of the 
basement membranes. a,-Macroglobulin also binds and 
can modify the activity of cytokines and growth factors 
[15]. Some of these, e.g. bFGF and TGFj?, influence 
patterns of growth and differentiation in the mammary 
gland [16]. 
In liver and in some hepatoma cell lines, the synthesis 
of a,-macroglobulin is mainly regulated by IL-6, al- 
though glucocorticoids are additionally required for 
maximum stimulation [8,9]. The precise requirements 
vary with the cell line. For example, in H-35 hepatoma 
cells, neither IL-6 nor dexamethasone alone are effec- 
tive but they act synergistically [17]. In FAO cells, 
dexamethasone alone is ineffective but greatly stimu- 
lates the induction of cc,-macroglobulin synthesis by IL- 
6 [lo]. IL-6 alone stimulates the synthesis of +mac- 
roglobulin by SH-SY 5Y neuroblastoma cells [4]. The 
myoepithelial cell line, G4.2.3, is somewhat unusual in 
that it is totally unresponsive to IL-6 alone, although 
IL-6 is able to synergise with glucocorticoids. These 
results suggest quantitative and/or qualitative differ- 
ences in the levels of transcription factors that regulate 
the response to IL-6. A possible explanation for the 
effectiveness of glucocorticoids in the absence of IL-6 
is that levels of IL-6 inducible transcription factors, e.g. 
IL6 RE-BPS [9,10], are already sufficiently high to per- 
mit transcription on addition of hydrocortisone. Such 
an explanation (in this case, high levels of C/EBP) has 
been proposed for the inability of IL-6 to regulate the 
expression of the cc,-acid glycoprotein gene in the rat 
hepatoma HTC cell line [18]. However, the 10 h lag 
phase before the glucocorticoid induction of a,-mac- 
roglobulin in G4.2.3 cells suggests arequirement for the 
synthesis of additional factors. This requirement can be 
partially overcome by IL-6 which reduces the lag phase 
to 4 h. The level of expression of IL-6 receptors in 
G4.2.3 cells is presently unknown. Glucocorticoids in- 
duce the synthesis of IL-6 receptors in some hepatoma 
cell lines [ 181 and consequently may induce responsive- 
ness to IL-6 in a previously unresponsive cell. 
Other cytokines, e.g. IL-l and TNFa, are known to 
affect the synthesis of az-macroglobulin, although the 
response varies depending on the cell lines [19]. The 
effects of IL-l may be mediated through IL-6. IL-l 
induces the synthesis of IL-6 in several types of cell [6]. 
The ability of TGFjI to regulate the expression of a,- 
macroglobulin is less well documented. In G4.2.3 cells, 
TGFj? has no effect on the synthesis of fibronectin but 
increases the synthesis of plasminogen activator inhibi- 
tor-l (PA&l) 6-fold (unpublished data). 
The rat mammary myoepithelial cell line, G4.2.3, 
thus appears to represent a useful system for studies on 
the regulation of a,-macroglobulin synthesis in a non- 
hepatic cell and on the control of myoepithelial differen- 
tiation during pregnancy. 
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